CoChat

Mechanisms of blood glucose homeostasis

Hers, H. ‐G. · 1990 · Journal of Inherited Metabolic Disease

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Abstract

Summary: The mechanisms by which glycogen metabolism, glycolysis and gluconeogenesis are controlled in the liver both by hormones and by the concentration of glucose are reviewed. The control of glycogen metabolism occurs by phosphorylation and dephosphorylation of both glycogen phosphorylase and glycogen synthase catalysed by various protein kinases and protein phosphatases. The hormonal effect is to stimulate glycogenolysis by the intermediary of cyclic AMP, which activates directly or indirectly the protein kinases. The glucose effect is to activate the protein phosphatase system; this occurs by the direct binding of glucose to glycogen phosphorylase which is then a better substrate for phosphorylase phosphatase and is inactivated. Since phosphorylase a is a strong inhibitor of synthase phosphatase, its disappearance allows the activation of glycogen synthase and the initiation of glycogen synthesis. When glycogen synthesis is intense, the concentrations of UDPG and of glucose 6‐phosphate in the liver decrease, allowing a net glucose uptake by the liver. Glucose uptake is indeed the difference between the activities of glucokinase and glucose 6‐phosphatase. Since the K m of the latter enzyme is far above the physiological concentration of its substrate, the decrease in glucose 6‐phosphate concentration proportionally reduces its activity. The control of glycolysis and of gluconeogenesis occurs mostly at the level of the interconversion of fructose 6‐phosphate and fructose 1,6‐bisphosphate under the action of phosphofructokinase 1 and fructose 1,6‐bisphosphatase. Fructose 2,6‐bisphosphate is a potent stimulator of the first of these two enzymes and an inhibitor of the second. It is formed from fructose 6‐phosphate and ATP by phosphofructokinase 2 and hydrolysed by a fructose 2,6‐bisphosphatase. These two enzymes are part of a single bifunctional protein which is a substrate for cyclic AMP‐dependent protein kinase. Its phosphorylation causes the inactivation of phosphofructokinase 2 and the activation of fructose 2,6‐bisphosphatase, resulting in the disappearance of fructose 2,6‐bisphosphate. The other major effector of these two enzymes is fructose 6‐phosphate, which is the substrate of phosphofructokinase 2 and a potent inhibitor of fructose 2,6‐bisphosphatase; these properties allow the formation of fructose 2,6‐bisphosphate when the level of glycaemia and secondarily that of fructose 6‐phosphate is high.

Overview

Integrity signals

Registry

Crossref · 10.1007/bf01799497

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 30 references

Research works printed but not linked: 1

  1. Hers H. G.Le Métabolisme du Fructose.Editions Arsia Bruxelles (1957) pp.200.

Cited by

Metadata

Authors
Hers, H. ‐.
Affiliations
UCLouvain (BE)
Corresponding author
Hers, H. ‐G.
Venue
Journal of Inherited Metabolic Disease
Publisher
Wiley
Published
1990-07
Volume
13
Issue
4
Pages
395-410
ISSN
  • 0141-8955 (ISSN-L)
  • 1573-2665
OpenAlex
W1997147019
Cited by
61
References
30
Citations by year
2025: 2 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 8 · 2020: 2 · 2019: 2 · 2018: 3 · 2017: 4 · 2016: 1 · 2015: 1 · 2014: 2 · 2013: 4 · 2012: 2
FWCI
0.57
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Inherited Metabolic Disease (publishedVersion)
  • PubMed (publishedVersion)
  • DIAL (Catholic University of Leuven) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
Keywords
blood glucose homeostasis, liver glycogen metabolism, glycogen phosphorylase, glycogen synthase, glycogen synthase phosphatase, cyclic AMP, protein kinases, protein phosphatase, glucose uptake, glucokinase, glucose-6-phosphatase, fructose-2,6-bisphosphate, phosphofructokinase-1, fructose-1,6-bisphosphatase, phosphofructokinase-2, fructose-2,6-bisphosphatase, bifunctional enzyme, glycolysis regulation, fructose-6-phosphate
MeSH terms
Animals, Blood Glucose, Gluconeogenesis, Glycogen, Glycolysis, Homeostasis, Humans

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.